MiR-210-3p attenuates lipid accumulation and inflammation in atherosclerosis by repressing IGF2
MiR-210-3p attenuates lipid accumulation and inflammation in atherosclerosis by repressing IGF2
复制标题
MiR-210-3p 通过抑制 IGF2 减轻动脉粥样硬化中的脂质积累和炎症
DOI:
10.1080/09168451.2019.1685370
复制
发表时间:
2019-11-03
影响因子:
1.6
通讯作者:
Chen, Tao
中科院分区:
文献类型:
--
作者:
Qiao, Xiang-Rui;Wang, Liang;Chen, Tao
Previous studies have shown that miR-210-3p is involved in the development and progression of atherosclerosis, but its specific mechanisms are still unclear. This study aims to reveal the mechanism of miR-210-3p and its target genes in macrophage lipid deposition and inflammatory response, and provide new ideas for the treatment of atherosclerosis. We found miR-210-3p increased sharply in the first 12 h induced by higher doses of ox-LDL in THP-1 macrophages and then gradually decreased. MiR-210-3p mimic transfection inhibited lipid uptake and inflammatory cytokine production in ox-LDL-induced macrophages. By inhibiting IGF2/IGF2R, miR-210-3p suppressed the expression of fatty acid transcriptase CD36 and transcription factor NF-kappa B in ox-LDL-induced macrophages. In conclusion, miR-210-3p inhibits the expression of CD36 and NF-kappa B by inhibiting IGF2 / IGF2R, thereby reducing lipid accumulation and inflammatory response in ox-LDL-induced macrophages. Enhancing miR-210-3p expression may be a new strategy for the treatment of atherosclerosis.